<--- Back to Details
First PageDocument Content
Enantiopure drugs / Hyperkalemia / Nephrology / Potassium / Diuretic / Salt substitute / Aliskiren / Potassium-sparing diuretic / Angiotensin II receptor antagonist / Chemistry / Medicine / ACE inhibitors
Date: 2014-07-15 21:11:58
Enantiopure drugs
Hyperkalemia
Nephrology
Potassium
Diuretic
Salt substitute
Aliskiren
Potassium-sparing diuretic
Angiotensin II receptor antagonist
Chemistry
Medicine
ACE inhibitors

RX FOCUS MORE @ WWW. PHARMACY TIMES.COM

Add to Reading List

Source URL: www.hanstenandhorn.com

Download Document from Source Website

File Size: 2,36 MB

Share Document on Facebook

Similar Documents

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

DocID: 1vj68 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uEgV - View Document

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA

DocID: 1uvE8 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uvxq - View Document

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

DocID: 1tmLJ - View Document